Cagent Vascular is a series b startup. 1 investor tracked.
Based in the United States, Cagent Vascular is a startup. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Cagent Vascular develops angioplasty balloons using proprietary serration technology to improve vessel preparation and outcomes in peripheral artery disease and chronic limb-threatening ischemia.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.